(Q51430550)

5 April 2018

title

Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass. (English)

1 reference

5 April 2018

1 reference

Hayashida N

1

1 reference

5 April 2018

Tomoeda H

2

1 reference

5 April 2018

Oda T

3

1 reference

5 April 2018

Tayama E

4

1 reference

5 April 2018

Chihara S

5

1 reference

5 April 2018

Kawara T

6

1 reference

5 April 2018

Aoyagi S

7

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 November 1999

1 reference

5 April 2018

The Annals of Thoracic Surgery

published in

1 reference

5 April 2018

volume

68

1 reference

5 April 2018

issue

5

1 reference

5 April 2018

page(s)

1661-1667

1 reference

5 April 2018

Inflammatory response to cardiopulmonary bypass

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Short-term use of intravenous milrinone for heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Clinical and haemodynamic effects of milrinone in the treatment of low cardiac output after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Modulation of TNF alpha and IL-1 beta from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Effect of theophylline on the production of interleukin-1 beta, tumor necrosis factor-alpha, and interleukin-8 by human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

The effects of norepinephrine on the release of cyclic AMP by the isolated perfused heart of the guinea pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Cyclic adenosine monophosphate decreases the secretion, but not the cell-associated levels, of interleukin-1 beta in lipopolysaccharide-activated human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Differential regulation of IL 6, IL 1 A, IL 1β and TNFα production in LPS-stimulated human monocytes: Role of cyclic AMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Oxpentifylline in endotoxaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Hypoxic stress induces cardiac myocyte-derived interleukin-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Effect of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Effects of minimal-dose aprotinin on coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

"Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900716-X

10.1016/S0003-4975(99)00716-X

7 January 2021

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018